In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other pharma stocks. Healthcare takes the concept of 'defensive' further than almost any ...

Another issue for investors is that Eli Lilly adjusted its guidance for the year, now projecting its adjusted EPS to fall ...

Eli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

The company maintains a moderate level of debt relative to its equity with a debt-to-equity ratio of 2.19, suggesting a relatively balanced financial structure. Key Takeaways For Eli Lilly in the ...

Eli Lilly and Company (NYSE: LLY) today announced that data from studies of Jaypirca® (pirtobrutinib), a non-covalent (reversible) Bruton's tyrosine kinase (BTK) inhibitor, will be presented at ...

An injection pen of Zepbound, Eli Lilly ... more, Lilly said. The drugmaker kept a lid on advertising Zepbound in the meantime, which may have dampened demand temporarily, the company said.

Shares of Eli Lilly & Co. LLY sank 0.01% to $806.06 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 1.23% to 5,782.76 ...

INDIANAPOLIS, Nov. 1, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: NYSE:LLY) today announced that data from the Phase 3 trial (EMBER-3) for imlunestrant, an oral selective ...

(Reuters) - Eli Lilly (NYSE:LLY) and Co said on Monday it will invest an additional $1.6 billion at its two new manufacturing sites in Indiana, United States to support the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...